3M CO Net Cash Provided by (Used in) Operating Activities, Continuing Operations
3M CO (MMM) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $988.00 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-04
- 3M CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was $988.00M, a 21.59% decline year-over-year.
- 3M CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was $2.21B, a 5.52% decline year-over-year.
- 3M CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was $1.91B, a 14.66% increase year-over-year.
- 3M CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was $1.28B, a 3.96% decline year-over-year.
- 3M CO net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was $5.30B.
- 3M CO net cash provided by (used in) operating activities, continuing operations for fiscal 2010 was $5.17B, a 4.72% increase from fiscal 2009.
- 3M CO net cash provided by (used in) operating activities, continuing operations for fiscal 2009 was $4.94B.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $988.00M 10-Q · filed 2017-05-03 | $3.20B derived: sum of 2 quarters · filed 2017-05-04 | $5.11B derived: sum of 3 quarters · filed 2017-05-04 | $6.39B derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | $2.21B derived: 8-K 12 month − 10-Q 9 month · filed 2017-05-04 | $4.12B derived: sum of 2 quarters · filed 2017-05-04 | $5.40B derived: sum of 3 quarters · filed 2017-05-04 | $6.66B 8-K · filed 2017-05-04 |
| 2016-09-30 | $1.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $3.19B derived: sum of 2 quarters · filed 2016-11-01 | $4.45B 10-Q · filed 2016-11-01 | $6.79B derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-06-30 | $1.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $2.54B 10-Q · filed 2016-08-02 | $4.88B derived: sum of 3 quarters · filed 2017-05-04 | $6.55B derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-03-31 | $1.26B 10-Q · filed 2017-05-03 | $3.60B derived: sum of 2 quarters · filed 2017-05-04 | $5.26B derived: sum of 3 quarters · filed 2017-05-04 | $6.60B derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $2.34B derived: 8-K 12 month − 10-Q 9 month · filed 2017-05-04 | $4.00B derived: sum of 2 quarters · filed 2017-05-04 | $5.34B derived: sum of 3 quarters · filed 2017-05-04 | $6.42B 8-K · filed 2017-05-04 |
| 2015-09-30 | $1.66B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $3.00B derived: sum of 2 quarters · filed 2016-11-01 | $4.08B 10-Q · filed 2016-11-01 | $6.26B derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-06-30 | $1.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $2.42B 10-Q · filed 2016-08-02 | $4.60B derived: sum of 3 quarters · filed 2017-05-04 | $6.31B derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-03-31 | $1.08B 10-Q · filed 2016-05-03 | $3.26B derived: sum of 2 quarters · filed 2017-05-04 | $4.97B derived: sum of 3 quarters · filed 2017-05-04 | $6.61B derived: sum of 4 quarters · filed 2017-05-04 |
| 2014-12-31 | $2.18B derived: 8-K 12 month − 10-Q 9 month · filed 2017-05-04 | $3.89B derived: sum of 2 quarters · filed 2017-05-04 | $5.53B derived: sum of 3 quarters · filed 2017-05-04 | $6.63B 8-K · filed 2017-05-04 |
| 2014-09-30 | $1.71B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $3.35B derived: sum of 2 quarters · filed 2015-10-29 | $4.44B 10-Q · filed 2015-10-29 | $6.44B derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-06-30 | $1.64B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $2.73B 10-Q · filed 2015-07-30 | $4.72B derived: sum of 3 quarters · filed 2016-05-17 | $5.88B derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-03-31 | $1.09B 10-Q · filed 2015-04-30 | $3.08B derived: sum of 2 quarters · filed 2016-05-17 | $4.24B derived: sum of 3 quarters · filed 2016-05-17 | $5.92B derived: sum of 4 quarters · filed 2016-05-17 |
| 2013-12-31 | $1.99B derived: 8-K 12 month − 10-Q 9 month · filed 2016-05-17 | $3.14B derived: sum of 2 quarters · filed 2016-05-17 | $4.82B derived: sum of 3 quarters · filed 2016-05-17 | $5.82B 8-K · filed 2016-05-17 |
| 2013-09-30 | $1.15B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $2.83B derived: sum of 2 quarters · filed 2014-10-30 | $3.82B 10-Q · filed 2014-10-30 | $5.56B derived: sum of 4 quarters · filed 2015-02-12 |
| 2013-06-30 | $1.68B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $2.67B 10-Q · filed 2014-07-31 | $4.41B derived: sum of 3 quarters · filed 2015-02-12 | $5.76B derived: sum of 4 quarters · filed 2015-02-12 |
| 2013-03-31 | $994.00M 10-Q · filed 2014-05-01 | $2.73B derived: sum of 2 quarters · filed 2015-02-12 | $4.08B derived: sum of 3 quarters · filed 2015-02-12 | $5.47B derived: sum of 4 quarters · filed 2015-02-12 |
| 2012-12-31 | $1.74B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $3.08B derived: sum of 2 quarters · filed 2015-02-12 | $4.47B derived: sum of 3 quarters · filed 2015-02-12 | $5.30B 10-K · filed 2015-02-12 |
| 2012-09-30 | $1.34B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $2.73B derived: sum of 2 quarters · filed 2013-10-31 | $3.56B 10-Q · filed 2013-10-31 | $5.30B derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-06-30 | $1.39B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $2.22B 10-Q · filed 2013-08-01 | $3.96B derived: sum of 3 quarters · filed 2014-05-15 | $5.32B derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-03-31 | $828.00M 10-Q · filed 2013-05-02 | $2.57B derived: sum of 2 quarters · filed 2014-05-15 | $3.93B derived: sum of 3 quarters · filed 2014-05-15 | $5.38B derived: sum of 4 quarters · filed 2014-05-15 |
| 2011-12-31 | $1.74B derived: 8-K 12 month − 10-Q 9 month · filed 2014-05-15 | $3.10B derived: sum of 2 quarters · filed 2014-05-15 | $4.55B derived: sum of 3 quarters · filed 2014-05-15 | $5.28B 8-K · filed 2014-05-15 |
| 2011-09-30 | $1.36B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $2.81B derived: sum of 2 quarters · filed 2012-11-01 | $3.55B 10-Q · filed 2012-11-01 | $5.18B derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | $1.45B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $2.18B 10-Q · filed 2012-08-02 | $3.81B derived: sum of 3 quarters · filed 2012-08-02 | |
| 2011-03-31 | $733.00M 10-Q · filed 2012-05-03 | $2.36B derived: sum of 2 quarters · filed 2012-05-03 | ||
| 2010-12-31 | $1.63B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $5.17B 10-K · filed 2012-02-16 | ||
| 2010-09-30 | $3.54B 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | $4.94B 10-K · filed 2012-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |